Yes, this would be a viable strategy to catch everyone off guard, but since it was promised to PR the first injection, I guess it won't happen. Anyway, there are enough catalysts for 2019 to move the SP significantly - blockbuster TNBC results or licensing/partnership news will allay all possible concerns.

Looking forward to monotherapy and mono trial news next week!